BARRIERS TO ADOPTION AND THE PATH FORWARD FOR BLOCKCHAIN IN CLINICAL RESEARCH AND HEALTHCARE DELIVERY

This session will describe barriers to adoption of blockchain and related technologies in clinical and translational research and evidence-based healthcare delivery, surveying blockchain challenge-areas including on- and off-chain governance, standards, regulation, mutualized ownership, capital formation, cross-chain interoperability, and more.  The role of IRBs in multi-site clinical research and NIH’s SMART IRB initiative will be highlighted along with the challenges of evolving pre-blockchain trust models that inform relationships between investigators, subjects, sites, public and private sector sponsors, CROs, peer-reviewed journals, IRBs, and regulators.  Places broader adoption of blockchain technology in research and healthcare delivery in context of its dynamic oversight and regulatory framework, including potential disruption of IRBs and the GDPR’s recent entry into force.
Heather Flannery, CEO, Obesity PPM